| Experts share how intervening early can help improve treatment success |
|
|
 |
|
| Anyone who has treated a dog for a chronic medical condition knows it can be challenging to keep a dog eating adequately. But it's critically important that they maintain nutritional intake for treatment success. |
|
|
|
|
|
| A recent Clinician's Brief article recaps a panel discussion among experts who shared their approaches to treating inappetence in dogs with chronic medical conditions. Read their insights now. |
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
| Stimulate appetite early to treat the whole picture. |
|
|
| At the first signs of reduced appetite, add ENTYCE® (capromorelin oral solution) as part of your overall treatment plan. |
|
|
|
 |
|
|
|
| • |
 |
Proven safe for long-term use1 |
|
|
| • |
|
Effectively stimulates appetite to help improve food consumption |
|
|
| • |
|
The ONLY FDA-approved appetite stimulant for dogs |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 Zollers B, Huebner M, Armintrout G, Rausch-Derra LC, Rhodes L. Evaluation of the safety in dogs of long-term, daily oral administration of capromorelin, a novel drug for stimulation of appetite. J Vet Pharmacol Ther. 2017 Jun;40(3):248-255. |
|
|
|
|
|
|
|
|
| IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail. |
|
|
|
|
|
|
|
